Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.24 CAD | +2.13% | -4.00% | -40.74% |
Mar. 22 | Diagnos Raises C$182,000 in the Final Tranche of a Private Placement of Share Units | MT |
Mar. 22 | DIAGNOS Inc. announced that it has received CAD 0.578 million in funding | CI |
Business Summary
Number of employees: 22
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Healthcare Services
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +10.69% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
93.9
%
| 0 | 92.9 % | 0 | 93.9 % | +11.79% |
United States
4.4
%
| 0 | 6.3 % | 0 | 4.4 % | -22.32% |
Mexico
1.5
%
| 0 | 0.3 % | 0 | 1.5 % | +541.43% |
Colombia
0.1
%
| - | - | 0 | 0.1 % | - |
Saudi Arabia
0.0
%
| 0 | 0.4 % | 0 | 0.0 % | -94.00% |
Costa Rica
0.0
%
| 0 | 0.1 % | 0 | 0.0 % | -86.29% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
André Larente
CEO | Chief Executive Officer | - | 00-09-20 |
Director of Finance/CFO | - | 08-04-30 | |
Chief Operating Officer | - | 16-12-31 | |
Sales & Marketing | - | 13-12-31 | |
Riadh Kobbi
PRN | Corporate Officer/Principal | - | 04-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Francis Bellido
BRD | Director/Board Member | - | 19-11-26 |
André Larente
CEO | Chief Executive Officer | - | 00-09-20 |
Vincent Duhamel
CHM | Chairman | 59 | 20-09-27 |
Robert Dunn
BRD | Director/Board Member | 70 | 20-09-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 75,584,300 | 64,377,470 ( 85.17 %) | 0 | 85.17 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.74% | 13.13M | |
-1.82% | 214B | |
+16.75% | 175B | |
+2.19% | 167B | |
+6.95% | 102B | |
+10.10% | 81.08B | |
+25.75% | 77.94B | |
-2.91% | 73.72B | |
-18.37% | 53.45B | |
+5.28% | 50.25B |
- Stock
- Equities
- Stock DIAGNOS Inc. - Toronto S.E.
- Company DIAGNOS Inc.